The quality of life of patients who undergo haematopoietic stem cell transplantation (HSCT) is affected by long periods of hospitalisation for the treatment of several complications. On this basis, 28 children who underwent 29 HSCTs were included in the Home Care (HC) programme of the Paediatric Haematology and Oncology Department of the Gaslini Children's Hospital to be discharged earlier. A total of 17 children were assisted for haematologic follow-up and support therapy administration. The remaining children were followed up for graftversus-host disease and/or cytomegalovirus infection. Overall activity consisted of 1232 i.v. therapies, 501 blood tests, 58 red blood cell or platelet transfusions, 107 procedures on Central Venous Catheter. Median duration of the assistance per child was 25 days (range 1-235) for a total of 1598 days. A total of 822 accesses at home replaced 459 and 363 out-patient and in-patient days of hospitalisation. The average cost per patient receiving HC (h4252) was significantly lower (Po0.01) when compared to the average cost per patient admitted to the hospital to undergo the same procedures (h14 693). This report shows that HC is feasible for children following HSCT, that it reduces the discomfort of the patients and their families, and that it reduces costs.
cology; haematopoietic stem cell transplantation
Over the last few years, haematopoietic stem cell transplantation (HSCT) has been increasingly offered for the treatment of both neoplastic and non-neoplastic diseases in children. Nonetheless, the toxic and infectious complications following this procedure often require long periods of hospitalisation, 1 and this causes discomfort both to the children and to their families, as well as an increase in the time on waiting lists for admission to Bone Marrow Transplantation (BMT) Units. Many of these patients (pts) do not require continuous medical supervision and may be cared for at home.
On the basis of these considerations, children who had undergone HSCT were considered eligible for admission to the Home Care (HC) programme of the G Gaslini Children's Hospital (GGCH) in Genova. 2 The aim was to reduce their physical and psychological discomfort, to increase early discharge so as to allow more critical patients access to the BMT Unit, and to reduce National Health Service (NHS) costs.
We report on the first 2 years of our HC programme for children who underwent HSCT.
Patients and methods
The HC programme of the Department of Haematology and Oncology of the GGCH was started in April 2000.
Inclusion and exclusion criteria for admission into HC are shown in Table 1 . Children entered the programme requiring at least one of the following procedures: blood tests, i.v. therapy, total parenteral nutrition (TPN), transfusions, and central venous catheter (CVC) procedure and/or use training. A physician was present during all transfusions of blood products. Known severe hypersensitivity to blood and platelet transfusions was considered a contraindication to performing these procedures at home.
The BMT Unit of our Department carries out an average of 50 transplants per year. More than half of the patients reside further than 500 km away and are usually housed in a residential facility near the Hospital or in flats run by volunteer associations.
Owing to the feasibility of the above-mentioned procedures, HC was considered a suitable option even for children undergoing HSCT.
HC rules require the physician who is responsible for the child to set up the programme together with the HC staff before suggesting it to the parents. Once the parents accept and sign the informed consent form, the HC physician becomes responsible for the organisation of the home accesses and follow-up.
The scheduled working time is 8 am to 4 pm, Monday to Friday. The remaining hours are covered by the physician on duty for the Department, who is available on call. The hospital provides the HC service with transfusion and laboratory support as well as i.v. drugs, and supplies all materials. Two cars are available, thanks to private donations, and their maintenance is supported by a volunteer association.
Results
Between April 2000 and April 2002, 28 children (21 males, seven females) out of the 78 who entered the HC programme were cared for, following 29 HSCT. Among them, two (7%) resided in Genova, while the remaining 26 (93%) resided in other parts of Italy and were therefore cared for in residential facilities that are partially run by volunteer associations. Median age at diagnosis was 5 years (range 1 month-13 years). Patients' age at the time of HC ranged between 6 months and 17 years (median 9 years). Table 2 reports the underlying diagnosis. Twenty of 29 transplants were performed from either unrelated (13 pts, 45%) or related donors (7 pts, 24%). Five (17%) and three (10%) of the remaining children underwent peripheral blood stem cell or autologous bone marrow transplant, respectively. One child (4%) received a cord blood transplant. Admission to HC was carried out at a median of 38 days (range 2-1348) after transplantation. In 24 cases (83%) admission to HC took place after the first discharge from the BMT Unit. The remaining five subjects (17%) entered HC after a period of follow-up in the outpatient clinic. Seventeen of 29 (59%) cases entered HC in order to undertake the standard follow-up after HSCT, which consists of blood tests, transfusions, and/or any further i.v. therapy that may be required, such as rehydration, TPN, or anti-infective therapy. The remaining children were being treated for cytomegalovirus (CMV) infection (four cases, 14%), graft-versus-host disease (GvHD) (three cases, 10%) treatment and follow-up, or for the simultaneous presence of these two diseases (five cases, 17%).
Six (20%) children had to be temporarily readmitted to the ward. Three of them were readmitted once, while the remaining three children were readmitted twice each. The causes for readmission were CMV infection (three cases), fever (three cases), pneumonia (one case), CVC blockage (one case), and ileostomy for intestinal grade IV acute GvHD (one case). All children continued the HC programme after being released from hospital.
Within the first 2 years of activity, 822 nurse and/or physician's visits were carried out, and this avoided 476 and 346 days of out-patient and in-patient clinic admission, respectively. Overall, the activities that were performed during these visits were as follows: 1232 i.v. therapies
By the end of March 2002, two children (7%) were still being assisted at home. Assistance was discontinued in 20 cases (68%) since the problems that had required HC were solved. Three children (10%) with acute leukaemia relapsed, and two of them went on receiving palliative care and died at home. The remaining four children (13%) left HC because of readmission to hospital with no further assistance at home: three of them left because of CMV infection, fungal pneumonia, and the onset of fever during neutropenia, respectively. In the fourth case, the cause of readmission was low compliance of the family to this kind of assistance.
As far as the financial aspects of this programme are concerned, we calculated the average cost of 1 day of HC (h150) by evaluating the mean cost per day of all the above-mentioned procedures performed during the whole period of activity, including the cost of i.v. drugs and supplies, plus the cost of staff. The cost of 1 day of outpatient (h350) or in-patient (h750) hospitalisation was based on the hospital's health directorate estimates. We measured the difference in cost to the NHS by counting the single physician's and/or nurse's visits, and used the following criteria to calculate how many out-patient and/or in-patient clinic days were avoided: patients undergoing either i.v. treatment more than twice a day or TPN administration were considered the ones who did not have to be admitted to the ward, whereas the remaining children were considered potential outpatient admissions. We used a t-test to compare the mean cost per patient undergoing HC to standard hospitalisation. The average cost of HC (h4252 range 150-30 450) was significantly lower (Po0.01) than the average cost that would have been charged to the NHS (h14 693, range 350-132 250) in the event of hospitalisation to perform the same procedures. Table 3 reports the number of HC days for each child entering the programme and the relative cost as compared to the number of days of outpatient or in-patient hospitalisation avoided. Home care programme in paediatric haemotology and oncology department M Miano et al
Discussion
Patients who undergo HSCT require long periods of follow-up to treat its toxic and infectious complications, and this often prevents them from being discharged earlier from hospital. 3 Therefore, in the last few years, outpatient clinic management of the post-transplant follow-up has improved in most centres. However, the amount of time spent at the outpatient clinic as well as the time needed to reach the hospital represent an important cause of discomfort for children and their families. HC proved to be feasible and useful for children suffering from cancer when therapy was administered for either curative [4] [5] [6] [7] [8] or palliative care. 9 HC has also proven feasible for adult patients after HSCT.
1 The 1-year Italian HC experience in our Paediatric Haematology and Oncology Institution has already been reported. 2 To our knowledge, this is the first report on an HC programme for children undergoing HSCT.
The financial advantages to be had with this kind of assistance 2, 10 have been confirmed, even when applied to children who undergo HSCT. The decrease in average cost per patient cared for at home was significant when compared to the cost of hospitalisation (Po0.01).
Although it has not been demonstrated by specific studies, HC seems to reduce the physical and psychological discomfort of children after HSCT by allowing early discharge from the BMT Unit and by decreasing the number of admissions to the out-patient clinic. In fact, the most frequent procedure administered at home was i.v. therapy, including TPN and antiviral treatment, which are the most common causes of delayed hospital discharge following transplantation. 3 In most cases, we were able to discontinue assistance when the indications for HC were solved. This meant that children who were discharged earlier from the BMT Unit did not need to be readmitted, except when severe infectious complications occurred. Nonetheless, the impression that this allowed us to make better use of available hospital beds must be confirmed by specific studies. At the same time, children and their families had the opportunity to avoid prolonging isolation from everyday life. Since most of the families come from other parts of the country, they were assisted in a residential facility close to the hospital or in flats partially run by a volunteer association. This allowed them to create a familiar environment and a social life in an unknown town. Families living in Genova had the opportunity to go on with their every day life and to carry on with their usual habits as much as possible. At the same time, all children received the necessary medical follow-up and therapy, they maintained a strong link with the Hospital staff, and above all, they were able to go back to their usual lifestyle. This was possible since it allowed them to leave the BMT Unit, which is a restricted ward, earlier than expected. The role of the psychologist was to strengthen the feeling of continuity of care, to support the patient, the family, and the staff, and to mediate their variety of needs that arise at home as compared to those that arise with standard hospitalisation.
Compliance of the families to HC was good in all cases but one. The decrease in the particularly restricted hospitalisation as well as the continuity offered by this service, thanks to the presence at home of Department personnel, helped the families to accept the programme. The difficulties that were encountered with the only family having low compliance to HC were partially because of language problems, since they came from a foreign country.
When HSCT failed, families were given the opportunity to go on with HC for palliative and support therapy administration, and this allowed them to avoid feelings of abandonment and to experience their coping abilities in a private environment. [11] [12] [13] This report shows that HC is feasible when applied to children discharged from BMT units, and that it reduces both their discomfort and the cost of assistance.
